Real-life effectiveness of tezepelumab in severe asthma
Real-life effectiveness of tezepelumab in severe asthma
About this item
Full title
Author / Creator
Miralles-López, Juan Carlos , Bravo-Gutierrez, Francisco-José , Andújar-Espinosa, Rubén , Castilla-Martínez, Manuel , Díaz-Chantar, Cayetano , Ramírez-Hernández, Mercedes , Cabrejos-Perotti, Sheila , Avilés-Inglés, Maria Jesús , Ibarra-Calabuig, Inmaculada , Reyes-Cotes, Miguel Henrique , Pajarón-Fernández, Manuel José , Bernabéu-Mora, Roberto , Alcalde-Rumayor, Consuelo , Alemany-Francés, María Loreto , Valverde-Molina, José , Pérez-Fernández, Virginia , RE-ASGRAMUR GROUP and RE-ASGRAMUR Group
Publisher
Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore
Subjects
More information
Scope and Contents
Contents
Background: Tezepelumab is a human monoclonal antibody which inhibits the cytokine thymic stromal lymphopoietin and is effective in different asthma endotypes. Methods: This is a prospective, multicenter study of the Register of Severe Asthma of the Region of Murcia (RE-ASGRAMUR) Group performed under routine clinical practice conditions. Results:...
Alternative Titles
Full title
Real-life effectiveness of tezepelumab in severe asthma
Authors, Artists and Contributors
Author / Creator
Bravo-Gutierrez, Francisco-José
Andújar-Espinosa, Rubén
Castilla-Martínez, Manuel
Díaz-Chantar, Cayetano
Ramírez-Hernández, Mercedes
Cabrejos-Perotti, Sheila
Avilés-Inglés, Maria Jesús
Ibarra-Calabuig, Inmaculada
Reyes-Cotes, Miguel Henrique
Pajarón-Fernández, Manuel José
Bernabéu-Mora, Roberto
Alcalde-Rumayor, Consuelo
Alemany-Francés, María Loreto
Valverde-Molina, José
Pérez-Fernández, Virginia
RE-ASGRAMUR GROUP
RE-ASGRAMUR Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3177621933
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3177621933
Other Identifiers
ISSN
0301-0546,1578-1267
E-ISSN
0301-0546,1578-1267
DOI
10.15586/aei.v53i2.1326
